Isiyobisi 'Ceforal solutab'. Imiyalelo

Iyeza "I-Ceforal solutab", iifomu zayo (amayeza "Supraks", "Iksim Lupine", "Panzef") yile nxalenye yee-antibacterial agents.

Amachiza "Ceforal Solutab" yintsebenziswano ye-third generation cephalosporin series. I-arhente inefuthe le-bactericidal, elihambelana nokukhutshwa kwe-synthesis ye-microbial wall cell. Isilwayo asixhatshazi kwimpembelelo ye-beta-lactamases (i-antibiotitic-destroying compounds eziveliswa nge-gram-negative ne-gram-positive bacteria).

Ukusebenza ngokugqithisileyo kweziyobisi kuphawulwe ezintathu okanye ezine iiyure emva kokungeniswa. Ukusetyenziswa kokutya akukho mpembelelo ebalulekileyo kwinqanaba lokutyunjwa kweziyobisi.

Isilwanyana "I-Ceforal solute" sinconywa ngezilonda ezithathelwanayo ze-ENT kunye neendlela zokuphefumula, izifo eziphene okanye ezingapheliyo. Isilwayo sinqunywe kwi-gonorrhea engathandekiyo kunye nezinye izifo zentsholongwane evuthayo, ebangelwa yiibhaktheriya ezibonisa ububele kumachiza.

Izigulane ezineminyaka elishumi elinamibini ezelwe ngemini zichazwe ngamakhulu ayi-miligram enye kanye okanye kabini.

Ithebhulethi inokuginywa okanye igutywe emanzini (isisombululo kufuneka sidakwe ngokukhawuleza emva kokulungiselela).

Ubungakanani bonyango kunye nesilwanyana "I-Ceforal solute" icetyiswa ngumyalelo ngokuhambelana nesimo sesifo. Njengomthetho, emva kokuphelisa zonke iimpawu zentsholongwane, iingcali zincoma ukuba ziqhubeke zithatha ezinye iintsuku ezimbini ukuya kwezine.

Ukuthintela ukubonakaliswa okungathandekiyo, ubude bonyango kwi-upper tractory tract or urinary tract lesions isekwe ngaphezu kweentsuku ezintlanu okanye ezilishumi, kunye neentsholongwane zecandelo elincinane lephepha lokuphefumula - iintsuku ezilishumi okanye ezilishumi elinanye. Ukuvuvukala kwindlebe ephakathi kukupheliswa kwiintsuku ezili-10 ukuya ku-14.

Kwiindawo zokugula ezinokubangwa yi- beta-hemolytic streptococcus A-iqela, ukukhusela ukuphuhliswa kweengxaki ezinjengexesha lika-glomerulonephritis okanye i-articular rheumatism kwisigaba esichukumisayo, umyalelo othi "I-Ceforal solute" imyalelo icebisa ukuthatha ubuncinane iintsuku ezilishumi.

Nge-gonorrhea engaxakekiyo yonyango eliye lalingeniswa kwimizi yama-milligram.

Unyango lwezilonda ezingenakunzima kwiphepha elingaphantsi lomchamo kubasetyhini luhlala iintsuku ezi-1-3.

Isilwanyana "I-Ceforal solute" umyalelo awuncomeli ukuthatha izigulane nge-porphyria, ukuxhomekeka kwintlungu (ku-anamnesis), isifo se-asthma. Isicatshulwa siyaphikisana nomntu ngamnye ochaphazelekayo kumacandelo.

Xa usebenzisa iyeza, ukuphuhliswa kweziphumo zecala kunokwenzeka. Isilwanyana singenza i-leukopenia, i-eosinophilia, i-pancytopenia, i-agranulocytosis okanye i-thrombocytopenia. Kunqabile kakhulu ekusebenzeni, kukho iimeko zokuphazamiseka komsebenzi we-clotting function.

Ukuphendulwa kwe-allergenki ngendlela ye-pruritus okanye i-urticaria ayinqabile. Ukufumana iziganeko ezingahambiyo ziquka i- Lyell's syndrome (iyeza kufuneka likhanselwe kulo mzekelo). Olunye ubonakaliso lokungabikho komzimba lungabandakanywa nophuhliso lwe-hypersensitive to the drug.

Kwezinye iimeko, xa uthatha imishanguzo "Ceforal solutab" inokuvela kwintlupheko, intlungu yesisu, i- pseudomembranous colitis, i- vaginitis, itching, u-jaundice okanye i-hepatitis.

Kufuneka kuqatshelwe ukuba umkhuba ubonisa ukuba izidakamizwa ziyaxhomekeka kakuhle zizigulane. Iyeza "I-Ceforal solutab" (ukugqithwa koogqirha kuhlaziywa) kungasetyenziswa ngexesha lokukhulelwa. Ukuqeshwa kunye nokubeka iliso kwimeko yesigulane kufuneka kwenziwe ngugqirha. Ukuba kuyimfuneko, thabatha iyeza elithi "Ceforol solute" ngexesha lokutya, ukondliwa kumiswa.

Ngaphambi kokuba usebenzise le mveliso kufuneka uqhagamshelane neengcali.